Limes Schlosskliniken AG: LIMES Schlosskliniken AG increases stake in Swiss clinic PRC Group AG
|
EQS-News: Limes Schlosskliniken AG
/ Key word(s): Investment/Investment
DGAP-Corporate News: LIMES Schlosskliniken AG: LIMES Schlosskliniken AG increases stake in Swiss clinic PRC Group AG LIMES Schlosskliniken AG, Cologne, 22.06.2023. LIMES Schlosskliniken AG has acquired a further PRC Group operates the world's most exclusive, individualized and discreet clinic for addiction and mental illness under the name Paracelsus Recovery. With teams of 15 doctors and therapists per patient, it treats mainly international UHNW clientele and prominent patients at its locations in Zurich and London. The financing of the transaction follows from liquid funds of the LIMES Group.
Paracelsus Recovery was founded in 2013 as a family-owned clinic and has established itself as the world’s leading clinic for addiction and mental illness. Besides its base in Zürich, since 2019 the clinic also treats patients in London. Furthermore, the clinic sends individual therapists and whole teams to support patients worldwide in their homes. The exclusive treatment offers are catering to an affluent international clientele such as business owners, top executives and public figures, as well as their family members, who seek not only the best possible and most intensive treatment options, but require strict confidentiality and a luxurious environment. More information can be found at www.paracelsus-recovery.com. The LIMES Schlosskliniken Group operates high-quality private clinics in Germany for stress-related illnesses, mental and emotional disorders, such as depression, affective disorders and acute burnout conditions. The range of services is aimed at private patients, those entitled to state aid and self-payers. The LIMES Schlosskliniken Group stands for the special approach of a relationship-oriented medicine in the treatment of people with mental illnesses. In addition to top medical quality, patients are offered a unique, protected and healing environment in which they can recover holistically. Further information is available at www.limes-schlosskliniken.de. Your contact person:
22.06.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | Limes Schlosskliniken AG |
| Kaiser-Wilhelm-Ring 26 | |
| 50672 Köln | |
| Germany | |
| ISIN: | DE000A0JDBC7 |
| WKN: | A0JDBC |
| Listed: | Regulated Unofficial Market in Dusseldorf |
| EQS News ID: | 1662735 |
| End of News | EQS News Service |
|
|
1662735 22.06.2023 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.